(Q36581425)

15 August 2017

1 reference

title

Therapy insight: management of cardiovascular disease in the renal transplant recipient (English)

1 reference

15 August 2017

main subject

cardiovascular disease

1 reference

Claudio Rigatto

1

1 reference

15 August 2017

Patrick Parfrey

series ordinal

2

1 reference

15 August 2017

language of work or name

1 reference

1 September 2006

1 reference

Nature Clinical Practice Nephrology

15 August 2017

published in

1 reference

15 August 2017

volume

2

1 reference

15 August 2017

issue

9

1 reference

15 August 2017

page(s)

514-526

1 reference

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

Acute myocardial infarction and renal dysfunction: a high-risk combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

Risk factors for accelerated atherosclerosis in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Ischemic heart disease--major cause of death and graft loss after renal transplantation in Scandinavia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Long-term changes in left ventricular hypertrophy after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Analysis of left-ventricular changes associated with chronic hemodialysis. A noninvasive follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Cardiovascular effects of successful renal transplantation: a 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Congestive heart failure in the community: trends in incidence and survival in a 10-year period.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

The epidemiology of heart failure: the Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Cardiac consequences of renal transplantation: changes in left ventricular morphology and function

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Left ventricular function before and after kidney transplantation. A prospective study in patients with juvenile-onset diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Effects of renal transplantation on left ventricular size and function

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Course of left ventricular hypertrophy and function in end-stage renal disease after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: an echocardiographic and pulsed Doppler study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Incidence and predictors of myocardial infarction after kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Cardiovascular complications after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Predicting coronary heart disease in renal transplant recipients: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Arterial hypertension and renal allograft survival

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Hypertension after kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Diabetes mellitus after kidney transplantation in the United States

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Hyperhomocysteinemia in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Hypertension in patients with chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Prevalence and management of anemia in renal transplant recipients: a European survey.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Pharmacoepidemiology of anemia in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Heart failure as a cause for hospitalization in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Impact of left ventricular hypertrophy on survival in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0253

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0253

1 reference

15 August 2017

1 reference